C40H49N4O9P Uridine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-methyl-, 3′ – [2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

productio

C40H49N4O9P Uridine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-methyl-, 3′ – [2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

Basic Information:


Product Detail

Product Tags

Substantia detail

Cas Subcriptio Number

110764-79-9

H335, H331, H319, H315, H311, H301 + H311 + H331, H301

Key physica proprietatibus Valor   Conditio
Pondus 760.81   -
Pka (praedicta) 9.39 ± 0.10   Most Acidic Temp: XXV ° C

Alia nomina et identifiers

Canonica ridet

N#CCCOP(OC1C(OC(N2C=CC(=O)NC2=O)C1OC)COC(C=3C=CC=CC3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5)N(C(C)C)C(C)C

Isomeric smiles

C(OC[C@@H]1[C@@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](OC)[C@@H](O1)N2C(=O)NC(=O)C=C2)(C3=CC=C(OC)C=C3)(C4=CC=C(OC) C = c4) C5 = c = c5 C5

INCHI

= Inchi 1s / c40h49n4o9p / c1-27 (II) XLIV (XXVIII (III) IV) LIV (51-25-11-23-41) 53-36-34 (52-38 (XXXVII) 42-39 (XLIII) XLVI) 26-50-40 (XLIII) XLIV) 26-50-40 (XLIII) XLIV) 26-50-40 (XLIII) XLVI) 2-9-8-10-13-29,30-14-18-32 (47-5) 19-15-30) 31-16-20-33 (48-6) 21-17-31 / H8-10.12-22.24,27-28,34,36-38h, 11,25-26H2,1-7H3,

(H, 42,45,46) / T34-, 36-, 37-, 38-, LIV? / M1 / ​​S1

Key Inchi

Uvuojolpndcihl, xkzjcbtisa, n

I aliud nomen huius substantiae

Uridine, V '-O- [bis (IV-metoxyphen) Phenylmethyl] -2 '-O-methyl-, III '- [II-cyanoethyl bis (I-methylethyl) phosphoramidite] (9CI)

Spectra praesto

Missa

Praedixit possessiones

Proprietatibus praesto
Biological
Proiectus
Lipinski
Structuram related

Biological

Res Valor Conditio Fons
Bioconcentration factor CCLIV PH I; Temp: XXV ° C (I) ACD
Bioconcentration factor MML PH II; Temp: XXV ° C (I) ACD
Bioconcentration factor (XV) CD PH III; Temp: XXV ° C (I) ACD
Bioconcentration factor (XLVI) PH IV; Temp: XXV ° C (I) ACD
Bioconcentration factor (LVII) D PH V; Temp: XXV ° C (I) ACD
Bioconcentration factor (LVIII) CM Ph VI; Temp: XXV ° C (I) ACD
Bioconcentration factor (LVIII) CM PH VII; Temp: XXV ° C (I) ACD
Bioconcentration factor (LVI) DCCC PH VIII; Temp: XXV ° C (I) ACD
Bioconcentration factor (XLII) CCC PH IX; Temp: XXV ° C (I) ACD
Bioconcentration factor (XII) CC PH X; Temp: XXV ° C (I) ACD

(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)

Proiectus

Res Valor Conditio Fons
Koc CCCLXXXIX PH I; Temp: XXV ° C (I) ACD
Koc MMMCXL PH II; Temp: XXV ° C (I) ACD
Koc (XXIII) DC PH III; Temp: XXV ° C (I) ACD
Koc (LXX) D PH IV; Temp: XXV ° C (I) ACD
Koc (LXXXVIII) C PH V; Temp: XXV ° C (I) ACD
Koc (IX) CCC Ph VI; Temp: XXV ° C (I) ACD
Koc (XC) CC PH VII; Temp: XXV ° C (I) ACD
Koc (LXXXVII) C PH VIII; Temp: XXV ° C (I) ACD
Koc (LXIV) DCCC PH IX; Temp: XXV ° C (I) ACD
Koc (XVIII) DCC PH X; Temp: XXV ° C (I) ACD

 

Res Valor Conditio Fons
logd 4.21 PH I; Temp: XXV ° C (I) ACD
logd 5.12 PH II; Temp: XXV ° C (I) ACD
logd 6.00 PH III; Temp: XXV ° C (I) ACD
logd 6,47 PH IV; Temp: XXV ° C (I) ACD
logd 6.57 PH V; Temp: XXV ° C (I) ACD
logd 6.58 Ph VI; Temp: XXV ° C (I) ACD
logd 6.58 PH VII; Temp: XXV ° C (I) ACD
logd 6.56 PH VIII; Temp: XXV ° C (I) ACD
logd 6,44 PH IX; Temp: XXV ° C (I) ACD
logd 5.90 PH X; Temp: XXV ° C (I) ACD
logp 6,581 ± 0.646 Temp: XXV ° C (I) ACD
Missam intrinsecam solubility 8.4 x 10-5 g / l Temp: XXV ° C (I) ACD
Missam solubility 0.019 g / l PH I; Temp: XXV ° C (I) ACD
Missam solubility 2.4 X 10-3 g / l PH II; Temp: XXV ° C (I) ACD
Missam solubility X 10-4 X G / l PH III; Temp: XXV ° C (I) ACD
Missam solubility X 10-4 G / l PH IV; Temp: XXV ° C (I) ACD
Missam solubility 8.4 x 10-5 g / l PH V; Temp: XXV ° C (I) ACD
Missam solubility 8.4 x 10-5 g / l Ph VI; Temp: XXV ° C (I) ACD
Missam solubility 8.4 x 10-5 g / l PH VII; Temp: XXV ° C (I) ACD
Missam solubility 8.4 x 10-5 g / l PH VIII; Temp: XXV ° C (I) ACD
Missam solubility X 10-4 G / l PH IX; Temp: XXV ° C (I) ACD
Missam solubility 10-4 X 10-4 g / l PH X; Temp: XXV ° C (I) ACD
Missam solubility 8.4 x 10-5 g / l Unbuffered aqua PH 7.00; Temp: XXV ° C (I) ACD
Molaris intrinsecam solubility X 10-7 Mol X / l Temp: XXV ° C (I) ACD
Molaris solubility 2.5 x 10-5 Mol / l PH I; Temp: XXV ° C (I) ACD
Molaris solubility 3.1 x 10-6 Mol / l PH II; Temp: XXV ° C (I) ACD
Molaris solubility 4.1 x 10-7 Mol / l PH III; Temp: XXV ° C (I) ACD
Molaris solubility X 10-7 Mol / l PH IV; Temp: XXV ° C (I) ACD
Molaris solubility X 10-7 Mol X / l PH V; Temp: XXV ° C (I) ACD
Molaris solubility X 10-7 Mol X / l Ph VI; Temp: XXV ° C (I) ACD
Molaris solubility X 10-7 Mol X / l PH VII; Temp: XXV ° C (I) ACD
Molaris solubility X 10-7 Mol X / l PH VIII; Temp: XXV ° C (I) ACD

 

Res Valor Conditio Fons
Molaris solubility 1.5 x 10-7 Mol / l PH IX; Temp: XXV ° C (I) ACD
Molaris solubility 5.2 x 10-7 Mol / l PH X; Temp: XXV ° C (I) ACD
Molaris solubility X 10-7 Mol X / l Unbuffered aqua PH 7.00; Temp: XXV ° C (I) ACD
Pondus 760.81    
PKA 9.39 ± 0.10 Most Acidic Temp: XXV ° C (I) ACD
PKA 3.45 ± 0.70 Maxime basic temp: XXV ° (I) ACD

(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)

Lipinski

Res Valor Conditio Fons
Sponte Rotatable vincula 18   (I) ACD
H acceptors 13   (I) ACD
H donos 1   (I) ACD
H donator / Acceptor Sum 14   (I) ACD
logp 6,581 ± 0.646 Temp: XXV ° C (I) ACD
Pondus 760.81    

(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)

Structuram related

Res Valor Source
Polar superficies regio CLV A2 (I) ACD

(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)

Praedicta Spectra

Spectra praesto
I h NMR
XIII c NMR

GHS aleam dicta

Codex Aleam dicitur Fons
H335 Sit causa respiratorii irritatio Peritus curated
H331 Toxicus si haustus Peritus curated
H319 Causa gravis oculus irritatio Peritus curated
H315 Causas cutis irritatio Peritus curated

 

Codex Aleam dicitur Fons
H311 Toxicus in contactum cum cutis Peritus curated
H301 + H311 + H311 Toxicus, si absorbuit, in contactu cum cutis aut haustus Peritus curated
H301 Toxicus, si absorptus Peritus curated

  • Previous:
  • Next:

  • Scribere nuntium hic mitte nobis